C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/71 (2006.01) A61K 31/4406 (2006.01) A61P 9/12 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2602442
The present invention provides novel compounds represented by the formula wherein R is as defined in the specification and wherein said compounds are useful for treating ocular hypertension and/or providing neuroprotection to the eye of a mammal.
L'invention porte sur de nouveaux composés de formule (I) dans laquelle: R est tel que défini dans les spécifications, lesdits composés s'avérant utiles pour traiter l'hypertension oculaire et/ou assurer la neuroprotection de l'oeil chez les mammifères.
Chen June
Woodward David F.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Ep2 receptor agonists for treating glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ep2 receptor agonists for treating glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ep2 receptor agonists for treating glaucoma will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1528773